Molecular Genetics and MetabolismPathologyPeer-reviewed journal article
Sex differences in alpha galactosidase protein processing and its impact on disease severity in Fabry disease
Lucia LavalleiD, Hibba KurdiiD, D Moreno Martinez, S Mangrati, Derralynn A. HughesiD
Abstract
Fabry disease (FD) is an X-linked disorder due to mutations in the -galactosidase A (GLA) gene. The condition is characterized by low GLA activity and accumulation of toxic sphingolipids. Some patients present full disease symptoms whereas others have one system affected, generally the heart or kidney. This suggests that a mutation in the GLA gene is necessary to cause FD, but other factors may contribute to its clinical expression. To investigates the impact of GLA mutant protein processing on GLA activity and disease expression, 26 individuals with FD (14 males) were studied. Clinical outcomes explored included the Mainz Severity Score Index (MSSI), the Age-Adjusting Severity Scores (AASS), glomerular filtration rate (GFR), and left ventricular mass index (LVMI). Globotriaosylsphingosine (lyso-Gb3) data was available for a subset of participants. Whole cell lysates were employed to assess GLA activity and GLA protein levels. Additionally, endoglycosidase H digestion was performed on cell lysates to quantify each GLA protein form: immature 50 kDa endoplasmic reticulum form and mature 46 kDa lysosomal form. The latter was employed to calculate lysosomal GLA activity and its relationship with clinical outcomes was studied. Fabry participants exhibited more of the immature form of GLA protein (0.23 vs 0.66, p= 0.04). Female patients exhibited higher total GLA activity (19.0 vs 5.1 nmol/hr/mg), total GLA protein levels 0.13 vs 0.50 GLA/LC, p= 0.003), and 46 kDa mature lysosomal form levels than male patients (0.53 vs 0.10, p= 0.001). Additionally, females showed a significant correlation between the GLA mature form and GLA activity (r2= 0.59, p= 0.04). Consistently, lysosomal GLA activity exhibited significant associations with MSSI (r2= -0.66, p= 0.02) and GFR (r2= 0.59, p= 0.04) only in this sex group. These results suggest that total GLA protein levels are linked to the severity of FD manifestations, particularly in females via enzyme activity.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 2th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- AGAL misprocessing-induced ER stress and the unfolded protein response: lysosomal storage-independent mechanism of Fabry disease pathogenesis?
Martina Živná, Gabriela Dostálová, … Stanislav Kmoch·bioRxiv·Sep 27, 2022
- Mitochondrial stress in Fabry disease
Lucia Lavalle, Hibba Kurdi, … Derralynn A. Hughes·bioRxiv·Sep 16, 2025
- Axon guidance deficits in a human sensory neuron model of Fabry disease
Christoph Erbacher, Aneeta Andrews, … Nurcan Üçeyler·Experimental NeurologyPeer-reviewed·Nov 21, 2025
- Nucleoside-Modified mRNA Encoding Alpha-Galactosidase A Reverses Fabry Disease Phenotypes in Human IPSC-Derived Cardiomyocytes
Malte Juchem, Sedef Ersoy, … Thomas Thum·bioRxiv·Dec 5, 2025
- Challenging the Conventional Treatment Initiation Paradigm: Early Detection of Irreversible Cellular Damage in Cardiac Biopsies of Fabry Disease Before the Formation of Gb3 Inclusion Bodies
Chung‐Lin Lee, Pei-Sin Chen, … Dau‐Ming Niu·medRxiv·Aug 7, 2023
- Early mitophagy defects and impaired mitochondrial energy metabolism drive target organ damage progression: lessons from the Fabry heart
Jessica Gambardella, Antonella Fiordelisi, … Guido Iaccarino·Cell ReportsPeer-reviewed·Oct 26, 2026